BioCentury | Oct 3, 2016
Financial News

Dilafor completes venture financing

...2016-09-27 Type: Venture financing Raised: SEK51 million ($5.9 million) Investors: Lee’s Healthcare Industry Investment Ltd.; Rosetta Capital...
BioCentury | Jul 10, 2015
Financial News

Karolinska Development reassesses portfolio value

...portfolio's value could fall to SEK320 million ($37.8 million) after accounting for potential distributions to Rosetta Capital...
BioCentury | Mar 24, 2014
Financial News

Rosetta Capital Ltd. financial update

...13 portfolio companies of Karolinska Development AB (SSE:KDEV, Solna, Sweden) (See BioCentury, March 18, 2013). Rosetta Capital...
BioCentury | Mar 24, 2014
Finance

Rosetta (mile)stones

...Rosetta (mile)stones Rosetta Capital Ltd. 's latest secondary equity acquisition fits into the firm's wheelhouse because the...
BioCentury | Mar 20, 2014
Financial News

Rosetta Capital buys part of pharma venture portfolio

Rosetta Capital Ltd. acquired undisclosed stakes in 20 companies from the corporate venture arm of an undisclosed "major pharmaceutical company." Rosetta invests in portfolios to provide liquidity to other investors or companies that wish to...
BioCentury | Feb 24, 2014
Financial News

Novimmune financial update

...in the round to CHF220 million ($246.6 million). The extension was led by new investor Rosetta Capital...
BioCentury | Feb 24, 2014
Company News

Novimmune board of directors update

...Novimmune S.A. , Plan-les-Ouates, Switzerland Business: Autoimmune, Inflammation, Transplant Appointed: Jonathan Hepple, partner at Rosetta Capital Ltd. WIR...
BioCentury | Feb 19, 2014
Financial News

Novimmune raises CHF60 million

...million ($67.3 million) in an extension of a series B round led by new investor Rosetta Capital...
BioCentury | Mar 18, 2013
Financial News

Karolinska Development financial update

...A syndicate led by VC firm Rosetta Capital (London, U.K.) paid SEK220 million ($34.4 million) to acquire...
BioCentury | Feb 18, 2013
Financial News

b-to-v Partners AG, Karolinska Development, Rosetta Capital Ltd. financial update

...Investment company b-to-v announced it was part of the syndicate led by VC firm Rosetta Capital which...
...24, 2012). b-to-v Partners AG , St Gall, Switzerland Karolinska Development AB (SSE:KDEV), Solna, Sweden Rosetta Capital...
Items per page:
1 - 10 of 17
BioCentury | Oct 3, 2016
Financial News

Dilafor completes venture financing

...2016-09-27 Type: Venture financing Raised: SEK51 million ($5.9 million) Investors: Lee’s Healthcare Industry Investment Ltd.; Rosetta Capital...
BioCentury | Jul 10, 2015
Financial News

Karolinska Development reassesses portfolio value

...portfolio's value could fall to SEK320 million ($37.8 million) after accounting for potential distributions to Rosetta Capital...
BioCentury | Mar 24, 2014
Financial News

Rosetta Capital Ltd. financial update

...13 portfolio companies of Karolinska Development AB (SSE:KDEV, Solna, Sweden) (See BioCentury, March 18, 2013). Rosetta Capital...
BioCentury | Mar 24, 2014
Finance

Rosetta (mile)stones

...Rosetta (mile)stones Rosetta Capital Ltd. 's latest secondary equity acquisition fits into the firm's wheelhouse because the...
BioCentury | Mar 20, 2014
Financial News

Rosetta Capital buys part of pharma venture portfolio

Rosetta Capital Ltd. acquired undisclosed stakes in 20 companies from the corporate venture arm of an undisclosed "major pharmaceutical company." Rosetta invests in portfolios to provide liquidity to other investors or companies that wish to...
BioCentury | Feb 24, 2014
Financial News

Novimmune financial update

...in the round to CHF220 million ($246.6 million). The extension was led by new investor Rosetta Capital...
BioCentury | Feb 24, 2014
Company News

Novimmune board of directors update

...Novimmune S.A. , Plan-les-Ouates, Switzerland Business: Autoimmune, Inflammation, Transplant Appointed: Jonathan Hepple, partner at Rosetta Capital Ltd. WIR...
BioCentury | Feb 19, 2014
Financial News

Novimmune raises CHF60 million

...million ($67.3 million) in an extension of a series B round led by new investor Rosetta Capital...
BioCentury | Mar 18, 2013
Financial News

Karolinska Development financial update

...A syndicate led by VC firm Rosetta Capital (London, U.K.) paid SEK220 million ($34.4 million) to acquire...
BioCentury | Feb 18, 2013
Financial News

b-to-v Partners AG, Karolinska Development, Rosetta Capital Ltd. financial update

...Investment company b-to-v announced it was part of the syndicate led by VC firm Rosetta Capital which...
...24, 2012). b-to-v Partners AG , St Gall, Switzerland Karolinska Development AB (SSE:KDEV), Solna, Sweden Rosetta Capital...
Items per page:
1 - 10 of 17